Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease

Autor: E, Sinakos, P, Panas, N, Fragkou, N, Antoniadis, G, Katsanos, E, Tsakni, T, Oikonomou, A, Notopoulos, G, Tsoulfas, I, Goulis, E, Akriviadis
Rok vydání: 2022
Předmět:
Zdroj: Acta Gastro Enterologica Belgica. 85:331-337
ISSN: 1784-3227
DOI: 10.51821/85.2.9577
Popis: Background and aims: Tenofovir alafenamide fumarate (TAF) was shown equally efficacious in suppressing hepatitis B virus (HBV) but with less renal toxicity than tenofovir disoproxil fumarate (TDF). The aim of this real-world study was to evaluate renal function in post-liver transplantation (LT) patients that changed TDF with TAF. Methods: The TAF group (n=17) included patients who switched to TAF due to low (
Databáze: OpenAIRE